Skip to content

The Impact of Postoperative Oliceridine Use on the Quality of Recovery in Patients Undergoing Lumbar Surgery

The Impact of Postoperative Oliceridine Use on the Quality of Recovery in Patients Undergoing Lumbar Surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102440
Enrollment
Unknown
Registered
2025-05-14
Start date
2025-05-19
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Vertebral Fracture/Spondylolisthesis

Interventions

Experimental Group:At the conclusion of surgery, oliceridine 0.02 mg/kg is administered intravenously. The patient-controlled analgesia (PCA) pump protocol is configured as follows: Oliceridine 0.3 m
Control Group:At the conclusion of surgery, fentanyl 0.001 mg/kg is administered intravenously. The patient-controlled analgesia (PCA) pump protocol is configured as follows: Fentanyl 0.015 mg/kg + gr

Sponsors

The Affiliated Hospital of Panzhihua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Aged between 18 and 65 years; (2)ASA physical status classification of I-II; (3)Scheduled for elective internal fixation for lumbar fracture or lumbar spinal fusion; (4)BMI between 18.5 and 28 kg/m²; (5)Signed informed consent form obtained.

Exclusion criteria

Exclusion criteria: (1)Chronic pain requiring long-term analgesic use; (2)Severe pulmonary hypertension, hepatic or renal dysfunction, or concurrent severe respiratory/cardiovascular diseases; (3)Abnormal ECG findings (e.g., sick sinus syndrome, second-degree or higher atrioventricular block, atrial fibrillation, QT interval prolongation >450 ms); (4)History of chronic alcoholism; (5)Pregnancy, lactation, or plans for pregnancy in the near future; (6)Psychiatric disorders or communication barriers; (7)Specific cases requiring postoperative tracheal intubation and transfer to the intensive care unit (ICU); (8)Investigator-deemed ineligibility.

Design outcomes

Primary

MeasureTime frame
QoR-15 Questionnaire Score;

Secondary

MeasureTime frame
Intraoperative Rocuronium Consumption and Extubation Time;PACU Rescue Analgesic Consumption;NRS Pain Score at Rest;Number of PCA administrations by the patient in 24 hours;24-hour consumption of analgesics;Use of rescue analgesics over 24 hours;Patient satisfaction;

Countries

China

Contacts

Public ContactFeng Zhu

The Affiliated Hospital of Panzhihua University

28261691@qq.com+86 139 8234 5569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026